APP and Alzheimer disease: The highly conserved class I transmembrane amyloid precursor protein (APP) is broadly expressed throughout nervous system development and has been extensively studied because its proteolytic processing is linked to Alzheimer’s disease (AD) (8–10), yet its physiological function, especially in humans, is unclear.